Health Sciences Acquisitions Corporation 2 (HSAQ) Financial Analysis & Valuation | Quarter Chart
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sec... more
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effec... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $149.23M | Exchange | NASDAQ |
| Sector | Financial Services | Industry | Shell Companies |
| Country | US | CEO | Roderick Tze Ian Wong |
| IPO Date | 2020-08-04 | CAGR | — |
| Employees | — | Website | — |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
HSAQ chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $849.32B | P/E | -532.4 | Forward P/E | — | PEG | — |
| P/S | 4.67 | P/B | 43954.82 | P/CF | -14563.43 | P/FCF | -2.53 |
| Sales | $31.98M | Sales 1Y | 1029.49% | Sales 3Y | inf% | Sales 5Y | — |
| EPS | $-0.03 | EPS 1Y | -72.88% | EPS 3Y | 417.46% | EPS 5Y | — |
| Sales QoQ | -20% | EPS QoQ | 15.15% | Sales QoQ Avg | 843.54% | EPS QoQ Avg | -98.18% |
| Gross Margin | 99.51% | Operating Margin | -181.36% | Profit Margin | -186.3% | ROCE | -56.73% |
| ROA | -51% | ROE | -151% | Altman Z Score | -3.04 | Piotroski Score | 4 |
| Current Ratio | 8.26 | Quick Ratio | 8.24 | Cash Ratio | 1.52 | Op. CF Ratio | -1.44 |
| Debt/Equity | 0.07 | Debt/Assets | 0.01 | Lt Debt/Equity | 0.03 | Lt Debt/Cap. | 0.03 |
| Intrst Cov. | 21.71 | Inventory Turnover | 0.63 | Asset Turnover | 0.28 | Receivables Turnover | 626.98 |
| Enterprise Value | $849.32B | P/E Ratio | -532.4 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 4.67 | P/B Ratio | 43954.82 |
| P/CF Ratio | -14563.43 | P/FCF Ratio | -2.53 |
| EPS | $-0.03 | EPS Growth 1Y | -72.88% |
| EPS Growth 3Y | 417.46% | EPS Growth 5Y | — |
| Revenue Growth 1Y | 1029.49% | Gross Margin | 99.51% |
| Operating Margin | -181.36% | Profit Margin | -186.3% |
| ROE | -151% | ROA | -51% |
| ROCE | -56.73% | Current Ratio | 8.26 |
| Quick Ratio | 8.24 | Cash Ratio | 1.52 |
| Debt/Equity | 0.07 | Interest Coverage | 21.71 |
| Altman Z Score | -3.04 | Piotroski Score | 4 |
View Health Sciences Acquisitions Corporation 2 financial charts →
Health Sciences Acquisitions Corporation 2 (HSAQ) valuation & financials
Health Sciences Acquisitions Corporation 2 (HSAQ) has a market capitalization of $149.23M and trades at a price-to-earnings ratio of -532.4. It operates in the Financial Services sector (Shell Companies).
Health Sciences Acquisitions Corporation 2's revenue grew +1029.5% over the last year.
Compare with other Financial Services companies: Berkshire Hathaway (BRK-B) · JPMorgan Chase (JPM) · Visa (V) · Mastercard (MA) · ICBC (1398.HK) · Agricultural Bank of China (601288.SS)
Health Sciences Acquisitions Corporation 2 revenue & earnings charts →